SEC Form 4 · accession 0001104659-16-093320
Ophthotech Corp. · OPHT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Samir Chandrakant Patel
Officer — President · Director
Period of report
Jan 29, 2016
Accepted (ET)
Feb 2, 2016 · 6:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410939
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jan 29, 2016 | S | 11,418 | $53.33 | D | 269,493 | D | |
| Common StockF3 | Jan 29, 2016 | S | 8,482 | $53.92 | D | 261,011 | D | |
| Common Stock | Jan 29, 2016 | S | 100 | $54.69 | D | 260,911 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2015.
- F2These shares were disposed of in multiple transactions on January 29, 2016 at actual sales prices ranging from $52.645 to $53.63 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3These shares were disposed of in multiple transactions on January 29, 2016 at actual sales prices ranging from $53.64 to $54.62 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.